Why Are Phase 3 Efficacy Clinical Trials No Longer Needed for Oncology Biosimilars? Authors: Paul Cornes, BM, BCh, MRCP, FRCR; Christian Buske, MD; Elena Guillén, MD, PhD

https://www.medscape.org/viewarticle/why-are-phase-3-efficacy-clinical-trials-no-longer-needed-2026a10015bk?page=1